Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery.

Kink JA, Forsberg MH, Reshetylo S, Besharat S, Childs CJ, Pederson JD, Gendron-Fitzpatrick A, Graham M, Bates PD, Schmuck EG, Raval A, Hematti P, Capitini CM.

Biol Blood Marrow Transplant. 2019 Nov;25(11):2124-2133. doi: 10.1016/j.bbmt.2019.07.026. Epub 2019 Aug 5.

PMID:
31394269
2.

PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells.

Zhu F, Guo H, Bates PD, Zhang S, Zhang H, Nomie KJ, Li Y, Lu L, Seibold KR, Wang F, Rumball I, Cameron H, Hoang NM, Yang DT, Xu W, Zhang L, Wang M, Capitini CM, Rui L.

Leukemia. 2019 Dec;33(12):2898-2911. doi: 10.1038/s41375-019-0489-6. Epub 2019 May 23.

PMID:
31123343
3.

90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma.

Hernandez R, Walker KL, Grudzinski JJ, Aluicio-Sarduy E, Patel R, Zahm CD, Pinchuk AN, Massey CF, Bitton AN, Brown RJ, Sondel PM, Morris ZS, Engle JW, Capitini CM, Weichert JP.

Commun Biol. 2019 Feb 26;2:79. doi: 10.1038/s42003-019-0327-4. eCollection 2019.

4.

CAR-T immunotherapy: how will it change treatment for acute lymphoblastic leukemia and beyond?

Capitini CM.

Expert Opin Orphan Drugs. 2018;6(10):563-566. doi: 10.1080/21678707.2018.1529562. Epub 2018 Oct 8.

5.

A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation.

Kim M, Rao S, Eickhoff JC, DeSantes KB, Capitini CM.

J Pediatr Hematol Oncol. 2020 Mar;42(2):145-148. doi: 10.1097/MPH.0000000000001422.

PMID:
30676436
6.

Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer.

Chapelin F, Capitini CM, Ahrens ET.

J Immunother Cancer. 2018 Oct 11;6(1):105. doi: 10.1186/s40425-018-0416-9. Review.

7.

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL.

Forsberg MH, Das A, Saha K, Capitini CM.

Ther Clin Risk Manag. 2018 Sep 3;14:1573-1584. doi: 10.2147/TCRM.S146309. eCollection 2018. Review.

8.

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.

Lieberman NAP, DeGolier K, Haberthur K, Chinn H, Moyes KW, Bouchlaka MN, Walker KL, Capitini CM, Crane CA.

Front Immunol. 2018 Feb 2;9:150. doi: 10.3389/fimmu.2018.00150. eCollection 2018.

9.

Bioengineering Solutions for Manufacturing Challenges in CAR T Cells.

Piscopo NJ, Mueller KP, Das A, Hematti P, Murphy WL, Palecek SP, Capitini CM, Saha K.

Biotechnol J. 2018 Feb;13(2). doi: 10.1002/biot.201700095. Epub 2017 Sep 18. Review.

10.

Neck Rhabdoid Tumors: Clinical Features and Consideration of Autologous Stem Cell Transplant.

Wolfe AD, Capitini CM, Salamat SM, DeSantes K, Bradley KA, Kennedy T, Dehner LP, Patel NJ.

J Pediatr Hematol Oncol. 2018 Jan;40(1):e50-e54. doi: 10.1097/MPH.0000000000000829.

11.

Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models.

Bouchlaka MN, Moffitt AB, Kim J, Kink JA, Bloom DD, Love C, Dave S, Hematti P, Capitini CM.

Biol Blood Marrow Transplant. 2017 Jun;23(6):897-905. doi: 10.1016/j.bbmt.2017.02.018. Epub 2017 Feb 28.

12.

Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease.

Elsaid MY, Capitini CM, Diamond CA, Porte M, Otto M, DeSantes KB.

Bone Marrow Transplant. 2016 Nov;51(11):1522-1523. doi: 10.1038/bmt.2016.153. Epub 2016 Jun 13. No abstract available.

13.

(19)F-MRI for monitoring human NK cells in vivo.

Bouchlaka MN, Ludwig KD, Gordon JW, Kutz MP, Bednarz BP, Fain SB, Capitini CM.

Oncoimmunology. 2016 Feb 18;5(5):e1143996. doi: 10.1080/2162402X.2016.1143996. eCollection 2016 May.

14.

FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

Li Y, Bouchlaka MN, Wolff J, Grindle KM, Lu L, Qian S, Zhong X, Pflum N, Jobin P, Kahl BS, Eickhoff JC, Wuerzberger-Davis SM, Miyamoto S, Thomas CJ, Yang DT, Capitini CM, Rui L.

Oncogene. 2016 Dec 1;35(48):6223-6234. doi: 10.1038/onc.2016.155. Epub 2016 May 9.

15.

JITC launches a new section: commentary and editorials.

Capitini CM, Romero P.

J Immunother Cancer. 2015 Jun 24;3:28. doi: 10.1186/s40425-015-0073-1. eCollection 2015. No abstract available.

16.

NK cell-based immunotherapies in Pediatric Oncology.

McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM.

J Pediatr Hematol Oncol. 2015 Mar;37(2):79-93. doi: 10.1097/MPH.0000000000000303. Review.

17.

Immunotherapy in pediatric malignancies: current status and future perspectives.

Capitini CM, Otto M, DeSantes KB, Sondel PM.

Future Oncol. 2014;10(9):1659-78. doi: 10.2217/fon.14.62. Review.

18.

Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD.

Capitini CM, Nasholm NM, Chien CD, Larabee SM, Qin H, Song YK, Klover PJ, Hennighausen L, Khan J, Fry TJ.

Blood. 2014 Sep 18;124(12):1976-86. doi: 10.1182/blood-2013-05-500876. Epub 2014 Jul 25.

19.

Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.

Shand JC, Qin H, Nasholm N, Capitini CM, Fry TJ.

Biol Blood Marrow Transplant. 2014 Jan;20(1):26-36. doi: 10.1016/j.bbmt.2013.10.009. Epub 2013 Oct 17.

20.

Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.

Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Gendron-Fitzpatrick A, Gumperz JE.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1310-22. doi: 10.1016/j.bbmt.2013.06.007. Epub 2013 Jun 24.

21.

Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.

Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ.

J Immunol. 2013 Feb 1;190(3):1351-9. doi: 10.4049/jimmunol.1200391. Epub 2012 Dec 28.

22.

Professional development session for early career scientists at SITC 2012.

Capitini CM, Redmond WL, Shafer-Weaver KA.

J Immunother Cancer. 2013 Jun 27;1:6. doi: 10.1186/2051-1426-1-6. eCollection 2013.

23.

Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".

Capitini CM, Gottschalk S, Brenner M, Cooper LJ, Handgretinger R, Mackall CL.

Pediatr Hematol Oncol. 2011 Sep;28(6):459-60. doi: 10.3109/08880018.2011.596615. Review. Erratum in: Pediatr Hematol Oncol. 2011 Oct;28(7):625.

PMID:
21854215
24.

Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.

Capitini CM, Davis JP, Larabee SM, Herby S, Nasholm NM, Fry TJ.

Biol Blood Marrow Transplant. 2011 Jun;17(6):790-9. doi: 10.1016/j.bbmt.2010.12.712. Epub 2011 Jan 7.

25.

Identification and characterization of two Bordetella avium gene products required for hemagglutination.

Temple LM, Miyamoto DM, Mehta M, Capitini CM, Von Stetina S, Barnes HJ, Christensen VL, Horton JR, Spears PA, Orndorff PE.

Infect Immun. 2010 Jun;78(6):2370-6. doi: 10.1128/IAI.00140-10. Epub 2010 Mar 29.

26.

Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Capitini CM, Fry TJ, Mackall CL.

Am J Immunol. 2009 Jan 1;5(3):65-83.

27.

Immunotherapy of childhood cancer: from biologic understanding to clinical application.

Wayne AS, Capitini CM, Mackall CL.

Curr Opin Pediatr. 2010 Feb;22(1):2-11. doi: 10.1097/MOP.0b013e3283350d3e. Review.

28.

Immune-based therapeutics for pediatric cancer.

Capitini CM, Mackall CL, Wayne AS.

Expert Opin Biol Ther. 2010 Feb;10(2):163-78. doi: 10.1517/14712590903431022. Review.

29.

Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Capitini CM, Chisti AA, Mackall CL.

J Intern Med. 2009 Aug;266(2):141-53. Review.

30.

Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.

Capitini CM, Cooper LJ, Egeler RM, Handgretinger R, Locatelli F, Sondel PM, Mackall CL.

J Pediatr Hematol Oncol. 2009 Apr;31(4):227-44. doi: 10.1097/MPH.0b013e31819a5d8d.

31.

Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.

Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ.

Blood. 2009 May 14;113(20):5002-9. doi: 10.1182/blood-2008-11-187385. Epub 2009 Mar 3.

32.

Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation.

Capitini CM, Derdak J, Hughes MS, Love CP, Baird K, Mackall CL, Fry TJ.

J Pediatr Hematol Oncol. 2009 Feb;31(2):142-4. doi: 10.1097/MPH.0b013e31819146e5.

33.

Wound infection with Neisseria weaveri and a novel subspecies of pasteurella multocida in a child who sustained a tiger bite.

Capitini CM, Herrero IA, Patel R, Ishitani MB, Boyce TG.

Clin Infect Dis. 2002 Jun 15;34(12):E74-6. Epub 2002 May 24.

PMID:
12032914
34.

Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo.

Koh CY, Blazar BR, George T, Welniak LA, Capitini CM, Raziuddin A, Murphy WJ, Bennett M.

Blood. 2001 May 15;97(10):3132-7.

PMID:
11342440

Supplemental Content

Loading ...
Support Center